C.ANIRUDH JAGANNADH; M.SRAVANI; DR M.D DHANARAJU. ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS. International Journal of Pharma and Bio Sciences, [S. l.], v. 4, n. 2, p. 750–754, 2013. Disponível em: https://ijpbs.net/index.php/journal/article/view/2225. Acesso em: 3 sep. 2026.